{
    "2019-09-24": [
        [
            {
                "time": "2019-10-01",
                "original_text": "Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023",
                "features": {
                    "keywords": [
                        "China",
                        "rising demand",
                        "drugs",
                        "pharma",
                        "growth"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-01",
                "original_text": "Pfizer Declares Fourth-Quarter 2019 Dividend",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "dividend",
                        "Fourth-Quarter",
                        "2019"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-01",
                "original_text": "Exact Sciences Gets FDA Nod for Label Expansion of Cologuard",
                "features": {
                    "keywords": [
                        "Exact Sciences",
                        "FDA",
                        "Cologuard",
                        "label expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-01",
                "original_text": "Pfizer Presents New Evidence of IBRANCE® (palbociclib) Effectiveness in HR+, HER2- Metastatic Breast Cancer Patients in Four Real-World Studies at ESMO Congress 2019",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "IBRANCE",
                        "effectiveness",
                        "breast cancer",
                        "ESMO Congress"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-01",
                "original_text": "European biotech firm BioNtech plans to raise nearly $304 mln in U.S. IPO",
                "features": {
                    "keywords": [
                        "BioNtech",
                        "IPO",
                        "fundraising",
                        "U.S."
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-01",
                "original_text": "LabCentral co-founder issues ‘call to action' to biotechs on drug pricing",
                "features": {
                    "keywords": [
                        "LabCentral",
                        "co-founder",
                        "call to action",
                        "drug pricing"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}